SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Pieris Pharmaceuticals Q1 EPS $(0.07) Beats $(0.17) Estimate, Sales $13.261M Beat $8.840M Estimate

Pieris Pharmaceuticals (NASDAQ:PIRS) reported quarterly losses of $(0.070) per share which beat the analyst consensus estimate of $(0.170) by 58.82 percent. This is a 65 percent increase over losses of $(0.200) per share

Benzinga · 05/11/2020 11:45

Pieris Pharmaceuticals (NASDAQ:PIRS) reported quarterly losses of $(0.070) per share which beat the analyst consensus estimate of $(0.170) by 58.82 percent. This is a 65 percent increase over losses of $(0.200) per share from the same period last year. The company reported quarterly sales of $13.261 million which beat the analyst consensus estimate of $8.840 million by 50.01 percent. This is a 55.19 percent increase over sales of $8.545 million the same period last year.